Table 3.
Model | pH | PaCO (mmHg) | MAP(CMV) | MAP(HFOV) | Admit hours | Intubated hours |
---|---|---|---|---|---|---|
(cmHO) | (cmHO) | pre-ECMO (log) | pre-ECMO (log) | |||
PedRESC | 0.46(100.0%) | 0.70(96.3%) | 1.37(93.9%) | 1.43(98.6%) | 1.42(99.3%) | 1.62(99.5%) |
PedRESC2 | 0.37(96.0%) | 0.67(76.9%) | 1.54(74.1%) | 1.59(83.4%) | 1.64(86.8%) | 2.30(95.7%) |
Standard | 0.99(58.8%) | 1.01(58.9%) | 1.01(55.6%) | 1.02(60.8%) | 1.01(58.4%) | 1.96(90.6%) |
NAB(Agn) | 0.58(94.5%) | 0.88(70.1%) | 1.29(84.3%) | 1.39(93.0%) | 1.33(91.5%) | 1.71(98.3%) |
NAB(Opt) | 0.55(97.5%) | 0.82(78.4%) | 1.33(88.7%) | 1.41(96.2%) | 1.36(95.7%) | 1.67(99.0%) |
SAB(Agn) | 0.90(73.7%) | 1.02(56.9%) | 1.10(69.2%) | 1.14(77.4%) | 1.03(59.2%) | 2.25(99.0%) |
SAB(Opt) | 0.86(76.9%) | 1.02(56.1%) | 1.13(71.4%) | 1.15(78.4%) | 1.02(58.1%) | 2.25(99.4%) |
Model | Malignancy | Pre-ECMO | DX:Asthma | DX:Bronchiolitis | DX:Pertussis | |
milrinone | ||||||
PedRESC | 1.22(95.1%) | 1.29(95.8%) | 0.75(93.9%) | 0.58(100.0%) | 1.33(99.5%) | |
PedRESC2 | 1.21(71.1%) | 1.31(76.6%) | 0.05(99.2%) | 0.76(75.1%) | 2.07(97.9%) | |
Standard | 1.00(50.8%) | 1.00(51.4%) | 0.94(69.8%) | 0.98(63.6%) | 1.33(85.2%) | |
NAB(Agn) | 1.15(80.7%) | 1.17(81.5%) | 0.70(91.4%) | 0.65(95.4%) | 1.43(98.8%) | |
NAB(Opt) | 1.17(87.0%) | 1.21(87.8%) | 0.71(93.6%) | 0.63(98.2%) | 1.40(99.4%) | |
SAB(Agn) | 1.03(59.2%) | 0.99(54.9%) | 0.96(60.6%) | 0.61(96.4%) | 1.50(96.8%) | |
SAB(Opt) | 1.03(59.5%) | 0.99(52.6%) | 0.97(60.0%) | 0.57(97.9%) | 1.49(96.9%) | |
Model | Abnormal | Bilirubin | ALT U/L (log) | Extent of | Extent of | Extent of |
pupillary resp. | mg/dL (log) | leukocyt. (log) | leukopen. (log) | thrombocytopen. (log) | ||
PedRESC | — | — | — | — | — | — |
PedRESC2 | — | — | — | — | — | — |
Standard | 0.99(56.4%) | 1.07(72.5%) | 5.60(99.8%) | 1.04(68.7%) | 0.97(66.6%) | 1.01(55.1%) |
NAB(Agn) | 0.99(55.1%) | 1.05(71.5%) | 4.88(99.6%) | 1.03(63.8%) | 0.98(62.5%) | 1.01(54.3%) |
NAB(Opt) | 0.99(54.6%) | 1.04(69.6%) | 4.92(99.5%) | 1.02(63.1%) | 0.98(61.5%) | 1.01(54.1%) |
SAB(Agn) | 0.99(57.5%) | 1.13(75.5%) | 4.87(99.8%) | 1.05(66.4%) | 0.95(66.5%) | 1.01(55.3%) |
SAB(Opt) | 0.99(57.8%) | 1.12(75.2%) | 4.60(99.7%) | 1.04(64.6%) | 0.96(65.1%) | 1.01(55.3%) |
Model | INR | VIS (log) | Lactate | PF ratio (log) | Pre-ECMO acute | |
mMol/L (log) | kidney injury | |||||
PedRESC | — | — | — | — | — | |
PedRESC2 | — | — | — | — | — | |
Standard | 1.02(62.0%) | 1.01(57.9%) | 1.57(85.6%) | 0.94(71.4%) | 1.00(53.7%) | |
NAB(Agn) | 1.01(57.9%) | 1.01(53.2%) | 1.10(77.6%) | 0.96(68.8%) | 1.00(50.2%) | |
NAB(Opt) | 1.01(56.7%) | 1.00(53.0%) | 1.07(75.1%) | 0.97(67.6%) | 1.00(50.0%) | |
SAB(Agn) | 1.05(66.8%) | 1.02(59.1%) | 1.94(90.7%) | 0.87(77.2%) | 1.00(52.8%) | |
SAB(Opt) | 1.05(66.8%) | 1.02(60.1%) | 1.97(90.6%) | 0.88(76.8%) | 1.00(51.9%) |
Results in bold have percentages exceeding 75.0%.